MedTrace Logo

Uterus Transplantation LD - Feasibility Study - Sahlgrenska - BMC

NCT03590405 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2021-12-15

No results posted yet for this study

Summary

Medical know-how concerning uterus transplantation will be transferred to new site by structured process involving theory, animal workshops and a clinical feasibility study on human subjects.

Conditions

  • Mrk Anomaly
  • Infertility, Female

Interventions

PROCEDURE

uterus transplantation surgery and IVF

IVF before surgery living donor uterus transplantation ET

Sponsors & Collaborators

  • Saint Joseph University, at Bellevue Medical Centre

    collaborator UNKNOWN

  • Sahlgrenska University Hospital

    lead OTHER

Principal Investigators

  • Mats Brännström, MD, PhD · Sahlgrenska University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-15
Primary Completion
2021-12-01
Completion
2021-12-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03590405 on ClinicalTrials.gov